Skip to main content

News & events

Featured article

All news & events

Batavia Biosciences Optimizes Global Quality Assurance with Veeva Vault Quality Suite

| News | No Comments
BARCELONA, Spain — September 15, 2022- Veeva Systems (NYSE: VEEV) today announced Batavia Biosciences selected Veeva Vault Quality Suite to optimize its global quality assurance (QA), unifying content, processes, and…

Batavia manufactures LASV vaccine candidate for IAVI who today announced the first vaccinations of their Lassa fever vaccine candidate

| News | No Comments
Batavia Biosciences would like to congratulate IAVI on their press release, as today they've announced volunteers in Monrovia, Liberia have been vaccinated with IAVI’s novel vaccine candidate against Lassa fever virus…

Batavia enters the commercial manufacturing business

| Featured, News | No Comments
Leiden, The Netherlands, June 28, 2022 – Today, Batavia Biosciences announces that it will extend its CDMO services portfolio (R&D and clinical manufacturing) to include commercial manufacturing services. The company…

Batavia produces lentivirus for first patient in the Netherlands successfully treated with stem cell gene therapy

| News | No Comments
It is with great enthusiasm and excitement that we would like to congratulate Leiden University Medical Center and the research team on their recent accomplishment using the lentivirus. Researchers have successfully…
Beagle Expansion

Batavia Biosciences increases capacity for viral vectors and vaccine R&D in Netherlands.

| News | No Comments
Leiden, The Netherlands,  June 14, 2022 – Today, Batavia Biosciences announces the expansion of its headquarters and R&D capacities in the Netherlands. The infrastructure increases capacity with another 22,500 sq.…
Best process development award 2022 vaccines

Batavia wins 2022 ViE Award for Best Process Development

| Featured, News | No Comments
Washington, April 20, 2022 - Batavia Biosciences was honored this week during the Vaccine Industry Excellence (ViE) Awards show at the World Vaccine Congress with the award for Best Production/Process…

Batavia Biosciences appoints Ron van Eijsden, Ph.D., as Head of Business Development

| News | No Comments
With Ron van Eijsden heading the Sales and Business Development team, Batavia expands its Management Team and reinforces its sales activities to support the ambitious expansion plans. In 2021, Batavia…

Batavia Biosciences joins the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

| News | No Comments
Woburn, MA, USA, March 22, 2022 -- Batavia Biosciences Inc. announces today that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). As an industry partner, Batavia…
CJ CheilJedang partners with Batavia Biosciences

Batavia Biosciences partners with CJ CheilJedang to propel its business expansion

| News | No Comments
Batavia Biosciences is proud to announce that CJ CheilJedang (Seoul, South Korea) has selected the company to advance its position in the red biotechnology field. In a press release today,…
HIP-Vax for ebolavirus vaccine

Batavia’s HIP-Vax® selected to propel IAVI’s VSV-vector based Sudan ebolavirus vaccine candidate from bench to clinic

| News | No Comments
Leiden, The Netherlands, October 28, 2021 – Batavia Biosciences is pleased to announce today that they are the manufacturing partner of IAVI’s Sudan ebolavirus vaccine candidate, rVSV∆G-SUDV-GP. The clinical trial…
Viral vector process development capacity

Batavia Biosciences is expanding its viral vector process development capacity in Massachusetts

| News | No Comments
Today, Batavia Biosciences announces the expansion of its process development facilities in Woburn, MA, United States to accommodate the increasing market demand for viral vectors. Chris Yallop, COO at Batavia…

Batavia successfully uses innovative HIP-Vax to manufacture IAVI’s Lassa fever vaccine candidate for Phase I clinical trials

| News | No Comments
Leiden, The Netherlands, July 14, 2021 – Batavia Biosciences announces today that they have successfully produced vaccine material for a Phase I clinical trial of IAVI’s Lassa fever vaccine candidate,…
HIP-vax clinical process development COVID-19 vaccine

Batavia to develop innovative clinical process for RocketVax’s second generation COVID-19 vaccine

| News | No Comments
Leiden, 6 July 2021 – Today, Batavia Biosciences announces their collaboration with RocketVax, a subsidiary of Swiss Rockets AG developing vaccines based on breakthrough genetic engineering. Under the agreement, Batavia…
Mascot kingfisher alec

Meet our newest team member: Alec

| News | No Comments
We would like to introduce you to our newest team member: kingfisher Alec! Alec is Batavia Biosciences' official mascot. In this post, we would like to explain how we found…
COVID-19 vaccine candidate

Batavia and KU Leuven join forces to accelerate development of highly promising COVID-19 vaccine candidate

| News | No Comments
Leiden, 3 December 2020 – KU Leuven, a leading research institution and one of the top 50 universities in the world and Batavia Biosciences, a contract development and manufacturing organization…

Batavia Biosciences and Valneva Collaborate to Accelerate Development of Low-cost Inactivated Polio Vaccine

| News | No Comments
Saint-Herblain, France, and Leiden, Netherlands, June 15, 2020 – Batavia Biosciences (“Batavia”) and Valneva Sweden AB, the Swedish subsidiary of Valneva SE (“Valneva”) today announced that they have entered into…
First clinical product manufactured with HIP-Vax platform

Batavia successfully navigating coronavirus pandemic

| News | No Comments
As the COVID-19 pandemic continues, we would like to update you on our business status. As a company at the forefront of epidemic preparedness, staying operational is critical as it…
Wistar Batavia Rubella Vaccine Collaboration

The Wistar Institute and Batavia Biosciences Launch Collaboration to Manufacture and Distribute Wistar’s Rubella Vaccine Globally

| News | No Comments
The Bill & Melinda Gates Foundation supports international collaboration to expand global access to life-saving vaccines PHILADELPHIA — (April 29, 2020) — The Wistar Institute and Batavia Biosciences announce the…
Immunotherapy development

Immutep and Batavia Biosciences announce pivotal milestone reached for LAG-3 immunotherapy development

| News | No Comments
Leiden, April 15, 2020 – Immutep and Batavia Biosciences announce today that they have successfully generated a high yielding cell line for an IgG4-based antibody for LAG-3 immunotherapy for autoimmune…

Collaboration with IAVI on VSV-vector Based Epidemic Preparedness Vaccines

| News | No Comments
Mutual expertise drives innovations to address supply issues for vaccines for outbreak pathogens NEW YORK — MARCH 5, 2020 — IAVI, a nonprofit scientific research organization dedicated to addressing urgent,…
10-year anniversary Batavia Biosciences

We are celebrating our 10-year anniversary!

| News | No Comments
Ten years ago, Christopher Yallop and Menzo Havenga incorporated Batavia Biosciences at the chamber of commerce in the Netherlands. The company started operations on January 1, 2010 at that time…
CEO Today healthcare awards 2019 Menzo Havenga

Menzo Havenga wins CEO Today Healthcare Award 2019

| News | No Comments
We are proud to announce that our CEO, Menzo Havenga, has won the CEO Today Healthcare Award 2019. Menzo is praised for his leading role in the biopharmaceutical medicines development…
Wistar Batavia Rubella Vaccine Collaboration

Batavia Biosciences to manufacture Marburg vaccine for IAVI under $35.7M DTRA grant

| News | No Comments
Leiden, the Netherlands, Nov 12, 2019 – We are proud to announce that we have partnered with IAVI under an award they have received from the US Defense Threat Reduction Agency…
Batavia Biosciences natoinal winner european business awards

National winner in European Business Awards for 3rd consecutive year

| News | No Comments
Batavia Biosciences has once again been selected as National Winner in the award category 'Innovation' in The European Business Awards, Europe’s largest business competition. The award to Batavia was granted…
Develop manufacturing process for polio - Batavia Biosciences

$6.5M grant to take next step towards polio-free world

| News | No Comments
Leiden, the Netherlands, Sep 16, 2019 – Today, Batavia Biosciences announces it received a grant of $6.5 million from the Bill & Melinda Gates Foundation to develop a manufacturing process…
CHO Cell Technology Batavia Biosciences Horizon Discovery

Batavia Biosciences to deploy Horizon Discovery’s CHO cell technology to develop anti-Zika biotherapeutic with Vanderbilt University Medical Center and IDBiologics

| News | No Comments
Leiden, 3 September 2019 – Today, Batavia Biosciences announced that the company has signed a license agreement to utilize Horizon Discovery’s GS knockout CHO K1 cell line expression system for…
Viral vaccine and viral vector manufacturing scale-up

$2.2 million follow-up grant from PATH to support new tools for polio eradication era

| News | No Comments
Leiden, 4 Jul 2019 – Today, Batavia Biosciences announces it received a follow-up grant of $2.2 million from PATH – a global organization dedicated to health equity – to develop…

$14.3M grant to deliver affordable measles & rubella vaccines

| News | No Comments
Grant from the Bill & Melinda Gates Foundation will support Univercells and partner Batavia Biosciences to develop a cost-effective manufacturing process and proceed towards the successful commercialization of measles and…
Batavia to develop viral vector-based vaccine Nipah virus

Batavia Biosciences partners with the University of Tokyo to develop a vector-based vaccine against Nipah virus

| News | No Comments
Leiden, the Netherlands, May 14, 2019 – Batavia Biosciences announced today that it will work together in a consortium including the European Vaccine Initiative and Stanford University, icddr,b, and headed…
Next-generation gene therapy for heart diseases

Next-Geneneration Gene Therapy for Patients with Heart Disease

| News | No Comments
The European Union has awarded €15 million to the CardioReGenix consortium, as part of the Horizon2020 program. The research program is initiated to develop new gene therapy approaches for the…

Batavia Biosciences receives $13.2M grant to accelerate market access of low-cost inactivated polio vaccine

| News | No Comments
Leiden, The Netherlands, February 25, 2019 – Batavia Biosciences announced today that it received a $13.2 million grant from the Bill & Melinda Gates Foundation to manufacture clinical-grade inactivated polio…
Breakthrough vaccine manufacturing platform

Introduction breakthrough vaccine manufacturing platform

| News | No Comments
Univercells, a business-to-business provider focused on increasing the availability of affordable biologics to address global health challenges, announced today the commercial launch of its proprietary NevoLine™ bioproduction system for vaccines.…
Live rotavirus vaccine formulation development

Batavia Biosciences partners with IAVI to advance development of vaccine against Lassa fever

| News | No Comments
Leiden, December 11th, 2018 – Batavia Biosciences announces today that the International AIDS Vaccine Initiative (IAVI) and Batavia Biosciences will work together under a grant to advance the development of…
FD Gazelle Award 2018 Batavia Biosciences

Batavia Biosciences wins FD Gazelle Award for 4th consecutive year

| News | No Comments
We are proud to announce that Batavia Biosciences has again been awarded with an FD Gazelle Award 2018 by the leading Dutch financial newspaper, Financieel Dagblad as one of the…
CEO of the year

CEO OF THE YEAR, 2018 title awarded to Batavia Biosciences!

| News | No Comments
We are pleased to announce that Dr. Menzo Havenga has been awarded the title CEO OF THE YEAR 2018- CONTRACT DEVELOPMENT AND MANUFACTURING. The European CEO Awards organization celebrates global business leaders that are…
Scientist Assays

Batavia Biosciences is Best Biopharmaceutical CDMO 2018

| News | No Comments
Today, GHP Announces Winners of the Healthcare & Pharmaceutical Awards 2018. We are very proud to announce that Batavia Biosciences has been awarded “Best Biopharmaceutical Contract Development & Manufacturing Company 2018”.…
Menzo Havenga Officer in Order Orange-Nassau

Menzo Havenga: Officer in the Order of Oranje-Nassau!

| News | No Comments
We are very proud that our CEO, Menzo Havenga, has been decorated in the Order of Orange-Nassau for his scientific achievements and his contributions to society. The Order of Orange-Nassau…
SATIRN® technology

Public-private consortium to propel Batavia Biosciences’ SATIRN technology for vaccine and antibody manufacturing

| News | No Comments
Leiden, 22 March 2018 - Leiden University has received a prestigious TTW-grant from the Netherlands Organization for Scientific Research (NWO) to collaborate with private partners ZoBio, and Batavia Biosciences to…
Most innovative company - Batavia Biosciences

Batavia Biosciences is the most innovative company 2017/2018 in the Netherlands

| News | No Comments
Brussels, 2 March 2018 - Batavia Biosciences has been selected as most innovative company in the Netherlands during an exclusive event held at the British Residence in Brussels for The…
Batavia Biosciences teams up with international consortium to support polio eradication

Batavia Biosciences teams up with international consortium to support polio eradication

| News | No Comments
Leiden, 16 January 2018 – Today Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV). The…
CEO of the Year 2017

Menzo Havenga awarded CEO of the year 2017 the Netherlands

| News | No Comments
We are very proud that the prestigious organization "CEO Monthly" has awarded the title of "CEO of the Year 2017 - Netherlands" to our Chief Executive Officer, Menzo Havenga. Menzo…
Platform Technologies Improve Protein Expression

Platform technologies improve protein expression

| News | No Comments
Platform technologies facilitate development and accelerate commercialization of protein therapeutics. Speed to market is essential in the biopharmaceutical industry today. Manufacturers are seeking mechanisms for increasing efficiencies and reducing costs without compromising the safety and…
Batavia Biosciences won FD Gazelle 2017 Award

We won FD Gazelle Award 2017!

| News | No Comments
Yesterday, Batavia Biosciences has been awarded with an FD Gazelle Award 2017 by the leading Dutch financial newspaper, Financieel Dagblad as one of the fastest growing mid-sized companies of the…
Expansion viral vector and GMP facilities

Batavia Biosciences expands its viral vector and GMP facilities to accommodate increasing market demand

| News | No Comments
Leiden, 16 October 2017 – Today, Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands…
SCID gene therapy consortium

Batavia Biosciences teams up with international gene therapy consortium under Horizon2020 program

| News | No Comments
An international consortium, headed by the group of Prof. Dr. Frank Staal (Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre) has been awarded a €6 million grant from…
Batavia Biosciences PEGS Boston

Novel plasmid technology at PEGS Boston

| News | No Comments
Our Director Operations, Marco Cacciuttolo, presented interesting new case studies for our STEP® Technology at the PEGS summit in Boston . For various 'difficult to express proteins' Batavia Biosciences was able to…
Grant Gates Foundation

Univercells and consortium partners Batavia Biosciences and Natrix Separations Received $12 Million Grant by Bill & Melinda Gates Foundation to Radically Reduce Vaccine Costs for Developing Countries

| News | No Comments
Univercells and consortium partners Batavia Biosciences and Natrix Separations selected by Bill & Melinda Gates Foundation to Radically Reduce Vaccine Costs for Developing Countries   Brussels, Belgium, December 15, 2016 – Univercells announced…
Batavia Biosciences - Biopharmaceutical Development

Batavia Biosciences receives grant to develop new vaccine against rotavirus

| News | No Comments
Leiden/Woburn, 21 September 2016 - Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable…

Batavia Biosciences Receives Grant from the Bill & Melinda Gates Foundation to Support Vaccine Availability in Developing Countries

| News | No Comments
Advanced cell-line technology could reduce costs of vaccine production Leiden, The Netherlands, and Woburn, MA, 9th June 2016 Batavia Biosciences is committed to increase vaccine availability and affordability for the developing…

CPHI Frankfurt

| Events | No Comments
Date: Nov 1-3 Location:  Frankfurt, Germany Contact: Pieter-Jan Vos It’s time for one of the best bioprocessing events of the year! Come join us at CPHI Frankfurt at Booth #91G03.…
Bio Europe Leipzig

BIO-Europe Leipzig

| Events | No Comments
Date:  24 - 26 October 2022 Location:  Leipzig, Germany Contact:  Pieter-Jan Vos Are your joining us at the BIO-Europe? Our team looks forward to meeting you in person again at…
BATAVIA_DNA_runner

ESGCT Edinburgh, Scotland 2022

| Events | No Comments
Date: 11-14 October Location: Edinburgh, Scotland Contact: Pieter-Jan Vos Meet us at the 29th European Society of Gene and Cell Therapy’s (ESGCT) Annual Meeting in Edinburgh, Scotland. We will be…
World Vaccine Congress Barcelona

World Vaccine Congress 2022 – Barcelona, Spain

| Events | No Comments
Date: 11-14 October Location: Barcelona, Spain Contact: Bjorn te Boekhorst Meet us at the World Vaccine Congress, an award-winning series of conferences and exhibitions that have grown to become the largest and…

ASGCT Washington, DC 2022

| Events | No Comments
Date: 16-19 May Location: Washington, USA Contact: Bjorn te Boekhorst Meet us at the 25th American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting in Washington D.C. from May…

BPI Europe 2022

| Events | No Comments
Date:  17- 20 May 2022 Location:  Vienna, Austria Contact:  Pieter-Jan Vos Will you be joining us at BPI Europe? Our team looks forward to meeting you in person again at…
BIO Europe Spring - Batavia Biosciences

BIO Europe Spring

| Events | No Comments
Date:  28 - 30 March 2022 Location:  Basel, Switzerland Contact:  Pieter-Jan Vos Are your joining us at the BIO Europe Spring event? Our team looks forward to meeting you in…
World Vaccine Congres US - Batavia Biosciences

World Vaccine Congress US

| Events | No Comments
Date: 18 - 21 April 2022 Location: Washington, USA Contact: Bjorn te Boekhorst It’s time for the most important vaccine event of the year! Come join us at the World…
World Vaccine Congress Europe Batavia Biosciences

World Vaccine Congress Europe

| Events | No Comments
Date: 10 - 13 October 2022 Location: Barcelona, Spain Contact: Pieter-Jan Vos We will be at the World Vaccine Congress in Barcelona. Our Director Project Management, Ahd Hamidi, will give…
World Vaccine and Immunology Congress - WVC West

World Vaccine & Immunotherapy

| Events | No Comments
Date:  30 November - 2 December 2021 Location:  San Diego, CA Contact:  Björn te Boekhorst Meet us at the World Vaccine & Immunotherapy congress November 30 to December 2, 2021…